Individuals with SCN also have a unique molecular profile of CH with 40% of individuals having truncating mutations in the cytoplasmic domain of granulocyte colony-stimulating factor receptor (CSF3R) compared with 0% of age-matched controls (35). This evidence concerns the gene CSF3R and severe congenital neutropenia.